In the current issue of the journal Spinal Cord
, an international panel of scientists and clinicians stake a position on "the sale of unproven cellular therapies for spinal cord injury." This position statement is must reading for all of us in this field because it lays out a series of rational and cogent arguments (some of which you may not have ever thought about) for not participating in unproven experimental treatments.
However, be aware that the last sentence in the statement is incorrect! Clearly it should read that the statement was endorsed by member organizations of the International Campaign for Cures of Spinal Cord Injury Paralysis (ICCP) and NOT the Institute for Certification of Computing Professionals.
You may also want to revisit the consumer version of the ICCP panel's guidelines for human clinical trials in spinal cord injury
, published several years ago in Spinal Cord.
Susan P. Howley
Executive Vice President, Research